HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF N-[2(S)-(MERCAPTOMETHYL)-3-(2-METHYLPHENYL)-1-OXO-PROPYL]-L-METHIONINE, THE ACTIVE PLASMA METABOLITE OF A PRODRUG ATRIOPEPTIDASE INHIBITOR (SCH-42495), USING A THIOL SELECTIVE (AU/HG) AMPEROMETRIC DETECTOR

被引:6
作者
ALTON, KB
HERNANDEZ, A
ALVAREZ, N
PATRICK, JE
机构
[1] Department of Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, Bloomfield, NJ 07003
来源
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 1992年 / 579卷 / 02期
关键词
D O I
10.1016/0378-4347(92)80396-8
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A high-performance liquid chromatographic assay for the determination of N-[2(S)-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]-L-methionine (SCH 42354; II), the active metabolite of the atriopeptidase inhibitor prodrug, N-[2(S)-(acetylthiomethyl)-3-(2-methylphenyl)-1-oxopropyl]-L-Methionine ethyl ester (SCH 42495; I), in human plasma was validated for use in clinical pharmacokinetic studies. Plasma (200-mu-l) was processed by protein precipitation with acetone containing the internal standard, N-[2(S)-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]-L-ethionine (III). Compound II was recovered (ca. 90%) in the supernatant after centrifugation and prepared for injection by the addition of 0.15 M monochloroacetic acid containing 0.2 mM EDTA. Separation of II and III was accomplished on commercially available reversed-phase C. columns designed for the separation of basic compounds. Both compounds were detected using amperometric detection (+0.125 V versus Ag/AgCl) on a thin-layer Au/Hg amalgam electrode. The lower limit of quantitation was 10 ng/ml, where the inter-assay precision (coefficient of variation) was +/-11.4% and the inter-assay accuracy (bias) was + 1.0%. No endogenous interferences were observed in the extracts obtained from drug-free plasma. The detector response (using either peak area or height ratios of II to III) was linear from 0.01 to 1.0-mu-g/ml. Compound II was stable in plasma supplemented with EDTA and sodium hydrogensulfite for at least 3 months when stored frozen at -78-degrees-C; no significant decomposition of II was observed following three freeze-thaw cycles. The feasibility of this liquid chromatographic assay with electrochemical detection was demonstrated with plasma samples from hypertensive subjects administered 100 mg of compound I.
引用
收藏
页码:307 / 317
页数:11
相关论文
共 20 条
  • [11] POTENTIATION OF THE DEPRESSOR RESPONSES TO ATRIAL NATRIURETIC PEPTIDES IN CONSCIOUS SHR BY AN INHIBITOR OF NEUTRAL ENDOPEPTIDASE
    SEYMOUR, AA
    SWERDEL, JN
    FENNELL, SA
    DRUCKMAN, SP
    NEUBECK, R
    DELANEY, NG
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 (02) : 194 - 204
  • [12] POTENTIATION OF RENAL EFFECTS OF ATRIAL NATRIURETIC FACTOR-(99-126) BY SQ 29,072
    SEYMOUR, AA
    FENNELL, SA
    SWERDEL, JN
    [J]. HYPERTENSION, 1989, 14 (01) : 87 - 97
  • [13] A LIQUID-CHROMATOGRAPHIC ELECTROCHEMICAL ASSAY FOR S-2-(3-AMINOPROPYLAMINO) ETHYLPHOSPHOROTHIOATE (WR2721) IN HUMAN-PLASMA
    SHAW, LM
    BONNER, H
    TURRISI, A
    NORFLEET, AL
    GLOVER, DJ
    [J]. JOURNAL OF LIQUID CHROMATOGRAPHY, 1984, 7 (12): : 2447 - 2465
  • [14] IDENTIFICATION OF PROTEASE-3.4.24.11 AS THE MAJOR ATRIAL NATRIURETIC FACTOR DEGRADING ENZYME IN THE RAT-KIDNEY
    SONNENBERG, JL
    SAKANE, Y
    JENG, AY
    KOEHN, JA
    ANSELL, JA
    WENNOGLE, LP
    GHAI, RD
    [J]. PEPTIDES, 1988, 9 (01) : 173 - 180
  • [15] SYBERTZ EJ, 1989, J PHARMACOL EXP THER, V250, P624
  • [16] TANG J, 1971, REGUL PEPTIDES, V9, P5384
  • [17] VEMULAPALLI S, 1991, AM J HYPERTENS, V4, pA16
  • [18] WATKINS RW, 1991, AM J HYPERTENS, V4, pA32
  • [19] DETERMINATION OF PENICILLAMINE, PENICILLAMINE DISULFIDE AND PENICILLAMINE GLUTATHIONE MIXED DISULFIDE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION
    YAMASHITA, GT
    RABENSTEIN, DL
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 491 (02): : 341 - 354
  • [20] YUMIBE N, COMMUNICATION